Debra Montgomery

2.0k total citations
31 papers, 820 citations indexed

About

Debra Montgomery is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Debra Montgomery has authored 31 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Infectious Diseases and 12 papers in Organic Chemistry. Recurrent topics in Debra Montgomery's work include HIV/AIDS drug development and treatment (13 papers), Hepatitis C virus research (9 papers) and Influenza Virus Research Studies (6 papers). Debra Montgomery is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), Hepatitis C virus research (9 papers) and Influenza Virus Research Studies (6 papers). Debra Montgomery collaborates with scholars based in United States, United Kingdom and Australia. Debra Montgomery's co-authors include Jennifer Fostel, Warren M. Kati, Dale J. Kempf, Clarence J. Maring, Linus L. Shen, Akhteruzzaman Molla, William E. Kohlbrenner, T. Ignasiak, O. P. Strausz and Paul A. Lartey and has published in prestigious journals such as Journal of Virology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Debra Montgomery

30 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Montgomery United States 18 384 250 240 185 132 31 820
Henri Moereels Belgium 14 441 1.1× 126 0.5× 213 0.9× 437 2.4× 82 0.6× 29 1.2k
Donghui Bao United States 10 361 0.9× 178 0.7× 342 1.4× 463 2.5× 43 0.3× 17 963
Lloyd Frick United States 19 501 1.3× 143 0.6× 409 1.7× 450 2.4× 87 0.7× 30 1.2k
Giulio Nannetti Italy 14 278 0.7× 165 0.7× 371 1.5× 126 0.7× 33 0.3× 19 703
Michel Garneau Canada 21 495 1.3× 212 0.8× 339 1.4× 289 1.6× 113 0.9× 57 1.3k
Henry J. Breslin United States 17 519 1.4× 525 2.1× 150 0.6× 756 4.1× 77 0.6× 27 1.4k
Yanming Du United States 21 434 1.1× 290 1.2× 371 1.5× 305 1.6× 96 0.7× 51 1.2k
Sandrine Vendeville France 11 184 0.5× 174 0.7× 195 0.8× 144 0.8× 87 0.7× 15 519
Antonin Kröhn United Kingdom 7 461 1.2× 307 1.2× 93 0.4× 647 3.5× 51 0.4× 9 1.1k
Chunhui Zhang China 17 531 1.4× 209 0.8× 76 0.3× 224 1.2× 144 1.1× 59 1.1k

Countries citing papers authored by Debra Montgomery

Since Specialization
Citations

This map shows the geographic impact of Debra Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Montgomery more than expected).

Fields of papers citing papers by Debra Montgomery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Montgomery. The network helps show where Debra Montgomery may publish in the future.

Co-authorship network of co-authors of Debra Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Montgomery. A scholar is included among the top collaborators of Debra Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Montgomery. Debra Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curtin, Michael L., H. Robin Heyman, Robin R. Frey, et al.. (2012). Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases. Bioorganic & Medicinal Chemistry Letters. 22(14). 4750–4755. 12 indexed citations
2.
Hutchinson, Douglas K., Charles A. Flentge, Rolf Wagner, et al.. (2011). Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety. Bioorganic & Medicinal Chemistry Letters. 21(6). 1876–1879. 7 indexed citations
3.
Palma, Joann P., Yichun Wang, Luis E. Rodrı́guez, et al.. (2009). ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors. Clinical Cancer Research. 15(23). 7277–7290. 111 indexed citations
4.
Randolph, John T., Charles A. Flentge, Peggy Huang, et al.. (2009). Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(10). 3174–3183. 34 indexed citations
5.
Pratt, John K., Clarence J. Maring, Warren M. Kati, et al.. (2008). Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 18(8). 2735–2738. 16 indexed citations
6.
Krueger, A. Chris, Yibo Xu, Warren M. Kati, et al.. (2008). Synthesis of potent pyrrolidine influenza neuraminidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(5). 1692–1695. 15 indexed citations
7.
Larson, Daniel P., Rolf Wagner, Todd W. Rockway, et al.. (2007). Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 568–570. 16 indexed citations
8.
Krueger, A. Chris, Darold L. Madigan, Douglas K. Hutchinson, et al.. (2007). Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives. Bioorganic & Medicinal Chemistry Letters. 17(8). 2289–2292. 17 indexed citations
9.
10.
Krueger, A. Chris, Darold L. Madigan, Wen Jiang, et al.. (2006). Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides. Bioorganic & Medicinal Chemistry Letters. 16(13). 3367–3370. 24 indexed citations
11.
Pratt, John K., Keith F. McDaniel, Clarence J. Maring, et al.. (2005). Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines. Bioorganic & Medicinal Chemistry Letters. 15(6). 1577–1582. 28 indexed citations
12.
Maring, Clarence J., Vincent S. Stoll, Chen Zhao, et al.. (2005). Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors. Journal of Medicinal Chemistry. 48(12). 3980–3990. 47 indexed citations
13.
Middleton, Timothy, Debra Montgomery, Todd W. Rockway, et al.. (2004). Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. Antiviral Research. 64(1). 35–45. 22 indexed citations
14.
Hanessian, Stephen, Debra Montgomery, Vincent S. Stoll, et al.. (2002). Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm. Bioorganic & Medicinal Chemistry Letters. 12(23). 3425–3429. 15 indexed citations
15.
Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (<I>μ</I>ARCS) to Identify Inhibitors of HIV Integrase. 7(3). 259–266. 1 indexed citations
16.
Middleton, Tim, Debra Montgomery, Hock Ben Lim, et al.. (2002). Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase. SLAS DISCOVERY. 7(3). 259–266. 24 indexed citations
17.
Kati, Warren M., Hing L. Sham, Jennifer McCall, et al.. (1999). Inhibition of 3C Protease from Human Rhinovirus Strain 1B by Peptidyl Bromomethylketonehydrazides. Archives of Biochemistry and Biophysics. 362(2). 363–375. 17 indexed citations
18.
Kati, Warren M., et al.. (1996). Novel Triterpene Sulfates from Fusarium compactum Using a Rhinovirus 3C Protease Inhibitor Screen.. The Journal of Antibiotics. 49(6). 541–546. 17 indexed citations
19.
Fostel, Jennifer, Debra Montgomery, & Paul A. Lartey. (1996). Comparison of responses of DNA topoisomerase I fromCandida albicansand human cells to four new agents which stimulate topoisomerase-dependent DNA nicking. FEMS Microbiology Letters. 138(2-3). 105–111. 12 indexed citations
20.
Fostel, Jennifer & Debra Montgomery. (1995). Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans. Antimicrobial Agents and Chemotherapy. 39(3). 586–592. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henri Moereels Breakdown of academic impact, for papers by Donghui Bao Breakdown of academic impact, for papers by Lloyd Frick Breakdown of academic impact, for papers by Giulio Nannetti Breakdown of academic impact, for papers by Michel Garneau Breakdown of academic impact, for papers by Henry J. Breslin Breakdown of academic impact, for papers by Yanming Du Breakdown of academic impact, for papers by Sandrine Vendeville Breakdown of academic impact, for papers by Antonin Kröhn Breakdown of academic impact, for papers by Chunhui Zhang
Rankless by CCL
2026